Nomura Holdings’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.4M | Buy |
60,151
+67
| +0.1% | +$11.7K | 0.03% | 397 |
|
|
2025
Q4 | $10.2M | Buy |
60,084
+45,708
| +318% | +$7.01M | 0.01% | 508 |
|
|
2025
Q3 | $1.89M | Sell |
14,376
-3,974
| -22% | -$477K | ﹤0.01% | 1156 |
|
|
2025
Q2 | $1.95M | Buy |
18,350
+8,133
| +80% | +$883K | ﹤0.01% | 843 |
|
|
2025
Q1 | $1.27M | Buy |
10,217
+2,195
| +27% | +$286K | ﹤0.01% | 1210 |
|
|
2024
Q4 | $988K | Buy |
8,022
+5,502
| +218% | +$648K | ﹤0.01% | 1476 |
|
|
2024
Q3 | $281K | Buy |
+2,520
| New | +$276K | ﹤0.01% | 1352 |
|
|
2024
Q2 | – | Sell |
-7,000
| Closed | -$843K | – | 1882 |
|
|
2024
Q1 | $843K | Buy |
+7,000
| New | +$857K | ﹤0.01% | 1148 |
|
|
2023
Q4 | – | Sell |
-10,000
| Closed | -$1.29M | – | 1867 |
|
|
2023
Q3 | $1.29M | Hold |
10,000
| – | – | ﹤0.01% | 903 |
|
|
2023
Q2 | $1.24M | Buy |
+10,000
| New | +$1.35M | ﹤0.01% | 854 |
|
|
2022
Q4 | – | Sell |
-5,004
| Closed | -$668K | – | 1595 |
|
|
2022
Q3 | $668K | Buy |
+5,004
| New | +$761K | ﹤0.01% | 1049 |
|
|
2021
Q3 | – | Sell |
-2,467
| Closed | -$438K | – | 2091 |
|
|
2021
Q2 | $438K | Buy |
+2,467
| New | +$427K | ﹤0.01% | 1418 |
|
|
2020
Q4 | – | Sell |
-28,000
| Closed | -$4M | – | 1583 |
|
|
2020
Q3 | $4M | Buy |
+28,000
| New | +$3.47M | 0.01% | 521 |
|
|
2019
Q3 | – | Sell |
-2,852
| Closed | -$406K | – | 1297 |
|
|
2019
Q2 | $406K | Sell |
2,852
-541
| -16% | -$72.7K | ﹤0.01% | 967 |
|
|
2019
Q1 | $485K | Buy |
3,393
+1,282
| +61% | +$167K | ﹤0.01% | 926 |
|
|
2018
Q4 | $261K | Sell |
2,111
-5,613
| -73% | -$833K | ﹤0.01% | 1055 |
|
|
2018
Q3 | $1.28M | Buy |
7,724
+3,427
| +80% | +$589K | ﹤0.01% | 859 |
|
|
2018
Q2 | $740K | Sell |
4,297
-1,309
| -23% | -$214K | ﹤0.01% | 924 |
|
|
2018
Q1 | $845 | Buy |
5,606
+2,826
| +102% | +$415K | ﹤0.01% | 1098 |
|
|
2017
Q4 | $374K | Buy |
+2,780
| New | +$386K | ﹤0.01% | 1367 |
|
|
2017
Q3 | – | Sell |
-6,950
| Closed | -$1.08M | – | 1548 |
|
|
2017
Q2 | $1.08M | Buy |
6,950
+2,073
| +43% | +$317K | ﹤0.01% | 1020 |
|
|
2017
Q1 | $709K | Buy |
4,877
+2,521
| +107% | +$328K | ﹤0.01% | 837 |
|
|
2016
Q4 | $257K | Sell |
2,356
-19
| -0.8% | -$2.12K | ﹤0.01% | 1384 |
|
|
2016
Q3 | $291K | Buy |
+2,375
| New | +$320K | ﹤0.01% | 1000 |
|
|
2016
Q2 | – | Sell |
-1,674
| Closed | -$218K | – | 1428 |
|
|
2016
Q1 | $218K | Sell |
1,674
-85
| -5% | -$10.6K | ﹤0.01% | 1201 |
|
|
2015
Q4 | $247K | Sell |
1,759
-1,121
| -39% | -$155K | ﹤0.01% | 1449 |
|
|
2015
Q3 | $389K | Sell |
2,880
-6,648
| -70% | -$1.14M | ﹤0.01% | 1065 |
|
|
2015
Q2 | $1.68M | Buy |
9,528
+1,277
| +15% | +$229K | ﹤0.01% | 895 |
|
|
2015
Q1 | $1.43M | Sell |
8,251
-4,659
| -36% | -$800K | ﹤0.01% | 717 |
|
|
2014
Q4 | $2.13M | Buy |
12,910
+1,893
| +17% | +$314K | 0.01% | 1019 |
|
|
2014
Q3 | $1.77M | Buy |
11,017
+368
| +3% | +$56.6K | ﹤0.01% | 1165 |
|
|
2014
Q2 | $1.57M | Sell |
10,649
-2,988
| -22% | -$414K | ﹤0.01% | 1252 |
|
|
2014
Q1 | $1.89M | Buy |
13,637
+2,650
| +24% | +$399K | ﹤0.01% | 1208 |
|
|
2013
Q4 | $1.39M | Sell |
10,987
-152
| -1% | -$15.7K | 0.01% | 856 |
|
|
2013
Q3 | $1.02M | Buy |
11,139
+3,569
| +47% | +$288K | 0.01% | 1075 |
|
|
2013
Q2 | $521K | Buy |
+7,570
| New | +$463K | ﹤0.01% | 1293 |
|
Other funds holding JAZZ
VPM
VCM
EC
Nomura Holdings's JAZZ Position: Q1 2026 in Review
Nomura Holdings increased its Jazz Pharmaceuticals (JAZZ) stake by 0.11% in Q1 2026, buying an estimated $11.7K and bringing the position to 60,151 shares worth $11.4M. The position accounts for 0.03% of the portfolio, ranked #397.
Nomura Holdings first reported a position in JAZZ in Q2 2013 and has held it in 36 quarters since. 573 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Nomura Holdings held 60,151 shares of Jazz Pharmaceuticals worth $11.4M as of Q1 2026.
- Nomura Holdings bought 67 Jazz Pharmaceuticals shares in Q1 2026, an estimated $11.7K.
- Jazz Pharmaceuticals made up 0.03% of Nomura Holdings's portfolio in Q1 2026, its #397 holding.
- Nomura Holdings first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 36 quarters since.
- 573 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.